
Yoshi Morishita joined the Shimaoka lab in 2007 as a
postdoctral fellow. His research focuses on the
therapeutic manipulation of leukocyte functions in
vivo. Dr. Morishita's long-term goal is to develop
effective anti-inflammatory treatment. He trained in
internal medicine with a sub-speciality in nephrology.
He is an awardee of the 2007 Uehara Memorial
Foundation's fellowship.
Contact:
Phone:
617-713-8384
E-mail: morishita@idi.harvard.edu
Postdoctoral Fellow
Department Anesthesia, Harvard Medical School
Immune Disease Institute
Education:
1996 M.D. Jichi Medical School
2006 Ph.D. Jichi Medical School
Position & Employment:
1996-1998 Clinical Fellow, Okayama Red Cross Hosp.
1998-2002 Postgrad. fellow, Okayama Univ.
2002-2004 Res. fellow, Jichi Medical School
2004-2007 Postgrad. fellow, Okayama Univ.
2007- Res. fellow, Harvard Medical School
Honors and Awards:
2007 Research Fellowship, The Uehara Memorial Foundation
Publications:
1. Morishita, Y., Sakube, Y., Sasaki S., Ishibashi, K. Aquaporin superfamily (superaquaporins): expansion of aquaporins restricted to multicellular organisms. J Pharmacol Sci. 2004. 96:276-279.
2. Nakakoshi, M., Morishita, Y., Usui, K., Ohtsuki, M., Ishibashi, K. Identification of a keratinocarcinoma cell line expressing AQP3. Biol Cell. 2006. 98: 95-100.
3. Li, H., Kamiie, J., Morishita, Y., Yoshida, Y., Yaoita, E., Ishibashi, K., Yamamoto, T. Expression and localization of two isoforms of AQP10 in human small intestine. Biol Cell. 2005. 97: 823-829.
4. Morishita, Y., Kita, Y., Ohtake, K., Kusano, E., Hishikawa, S., Mizuta, K., Kawarasaki, H.Successful treatment of sepsis with polymyxin b-immobilized fiber hemoperfusion in a child after living donor liver transplantation. Dig Dis Sci. 2005. 50: 757.
5. Morishita, Y., Ando, Y., Ishii, E., Arisaka, M., Kusano, E. Comparison of markers of circulating blood volume in hemodialysis patients. Clin Exp Nephrol. 2005. 9: 233-237.
6. Masuda, T., Morishita Y., Homma, S., Kobayashi, A., Kajii, E., Asano, Y., Kusano, E. Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria and autoimmune hemolytic anemia. Am J Hematol. 2005. 78: 159.
7. Morishita, Y., Matsuzaki, T., Hara-chikuma, M., Andoo, A., Shimono, M., Matsuki, A., Kobayashi K, Ikeda M, Yamamoto T, Verkman A, Kusano E, Ookawara S, Takata K, Sasaki S, Ishibashi K. Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule.Mol Cell Biol. 2005. 25: 7770-7779.
8. Morishita Y, Uenaka A, Kaya S, Sato S, Aji T, Nakayama E.
HLA-DRB1*0410 - restricted recognition of XAGE-1b37-48 peptide by CD4 T cells. Microbiol Immunol. 2007;51(8):755-62.
9. Peer, D., Park, E.J., Morishita, Y., Carman, C.V., Shimaoka, M. 2008 Systemic leukocyte-directed sirNA delivery revealing cyclin D1 as an anti-inflammatory target. Science. 2008. 319: 627-630.